On Wednesday, June 15, 2022, in a unanimous decision, the U.S. Supreme Court decided in favor of the American Hospital Association in the case of American Hospital Association vs. Becerra, that the nearly 30 percent cuts in...more
6/22/2022
/ American Hospital Association ,
American Hospital Association et al v Becerra Secretary Of Health And Human Services et al ,
Centers for Medicare & Medicaid Services (CMS) ,
Drug Pricing ,
Health Care Providers ,
Hospitals ,
Medicare ,
Medicare Part B ,
Prescription Drugs ,
SCOTUS ,
Section 340B
President Trump's fiscal year 2020 (FY20) budget proposal for the Department of Health and Human Services (HHS) reflects the Trump Administration's priorities to repeal and replace the Affordable Care Act (ACA), implement...more
3/18/2019
/ Affordable Care Act ,
Cost-Sharing ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicaid ,
Medicare ,
Opioid ,
Popular ,
Prescription Drugs ,
Section 340B ,
Trump Administration
Health care issues will remain a central focus in Washington throughout 2019. Having gained control of the House following the 2018 mid-term elections, Democrats now have the ability to block President Trump's legislative...more
2/12/2019
/ Affordable Care Act ,
Block Grants ,
Centers for Medicare & Medicaid Services (CMS) ,
CMMI ,
Congressional Oversight ,
Constitutional Challenges ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid Expansion ,
Medicare ,
Medicare for All ,
Political Parties ,
Popular ,
Prescription Drugs ,
Repeal ,
Stark Law ,
State Medicaid Programs ,
Trump Administration ,
Waivers
The Administration has continued its push to address the issue of high drug prices through the regulatory process. On October 15, 2018, the Department of Health and Human Services (HHS) issued a proposed rule to require drug...more
After months of hearings and negotiations, lawmakers reached agreement on a bipartisan package to address prevention, treatment, research, and enforcement related to the misuse of and addiction to opioids....more
Given broad interest in addressing opioid abuse and growing public pressure, lawmakers have considered a broad range of bills designed to address opioids, intending to pass legislation during the summer to demonstrate action...more
Given broad interest in addressing opioid abuse and growing public pressure, both the House and Senate are considering a broad range of bills designed to address opioids, with lawmakers working to pass legislation during the...more
Health and Human Services (HHS) Secretary Alex Azar has continued to promote and expand on the Trump Administration's new Drug Pricing Blueprint through media appearances and congressional testimonies over the past several...more
On Friday, May 11, President Donald Trump and Department of Health and Human Services (HHS) Secretary Alex Azar presented the Administration's long-awaited plan to address drug pricing. The proposed framework, entitled,...more
The Department of Health and Human Services (HHS) is soliciting comments from the public on the Administration's proposals to reduce drug prices and is targeting the 340B drug pricing program as an area of focus. ...more
Health care stakeholders, the Administration, and Congress are likely to continue responding to the worsening nationwide opioid abuse epidemic. Last October, President Trump declared a Nationwide Public Health Emergency to...more
Despite President Trump's pledge to rein in prescription drug pricing, the Administration did not take substantial action to address this issue in 2017. With the expected confirmation of Alex Azar – who is a former Eli Lilly...more
On July 12, the House passed a five-year reauthorization of four different user fee agreements that account for over a quarter of the Food and Drug Administration's (FDA) overall funding. The legislation, titled "The Food and...more
On May 11 and June 7, the Senate HELP Committee and House Energy and Commerce Committee, respectively, both advanced bipartisan legislation to reauthorize four different user fee agreements that account for over a quarter of...more
In July, after months of negotiation, Congress overwhelmingly passed compromise legislation authorizing nearly $900 million in spending to help fight the growing opioid abuse crisis. The measure, which passed the Senate 92 to...more
FY17 Appropriations -
The House and Senate Appropriations Committees continue to move forward on individual FY17 spending measures based on discretionary spending levels enshrined in last fall's bipartisan budget deal....more
5/2/2016
/ Air Traffic Control Systems ,
Centers for Medicare & Medicaid Services (CMS) ,
Continuing Resolution ,
Federal Aviation Administration (FAA) ,
Federal Budget ,
Fiduciary Duty ,
Fiscal Year ,
Food and Drug Administration (FDA) ,
Legislative Agendas ,
Managed Care Contracts ,
Medicaid ,
Medicare Access and CHIP Reauthorization (MACRA) ,
Mental Health ,
Opioid ,
Prescription Drugs ,
Rural Development ,
Urban Planning & Development ,
Zika
With only a handful of items currently active on the House and Senate agendas, FY17 appropriations legislation is the major legislative game in town. The House and Senate Appropriations Committees are moving forward with...more
4/1/2016
/ Airports ,
Appropriations Bill ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Labor (DOL) ,
Drug & Alcohol Abuse ,
Drug Pricing ,
Fair Labor Standards Act (FLSA) ,
Federal Aviation Administration (FAA) ,
Federal Budget ,
HELP ,
Infectious Diseases ,
Legislative Agendas ,
Medicare Part B ,
Military Service Members ,
Opioid ,
Over-Time ,
Physician Medicare Reimbursements ,
Prescription Drugs ,
Telemedicine ,
TRICARE ,
Wage and Hour ,
White-Collar Exemptions ,
Zika